A huge opportunity exists for a group of biotech stocks seeking to “hijack the immune system” with bispecific antibodies. Just what are bispecific antibodies – the global market for which could hit $12 billion by 2026 – and which biotech stocks are working in this exciting space with huge growth potential? CLICK HERE.
Hijacking The Immune System Creates A Huge Opportunity For These Biotech Stocks
- by davidgoldstein
- February 13, 2021April 17, 2021